共 50 条
Cardiac hypertrophy in polycythemia vera: A case report and review of literature
被引:0
作者:
Ma, Bai-Sheng
[1
,2
,3
,4
]
Zhai, Shu-Hui
[1
,2
,3
,4
]
Chen, Wei-Wei
[1
,2
,3
,4
]
Zhao, Qi-Ni
[1
,2
,3
,4
]
机构:
[1] Jilin Univ, Dept Cardiol, China Japan Union Hosp, 126 Xiantai St, Changchun 130031, Jilin, Peoples R China
[2] Jilin Prov Cardiovasc Res Inst, Dept Cardiol, Changchun 130031, Jilin, Peoples R China
[3] Jilin Univ, Dept Cardiol, Changchun, Peoples R China
[4] Jilin Univ, Dept Cardiol, Changchun, Peoples R China
来源:
WORLD JOURNAL OF CARDIOLOGY
|
2024年
/
16卷
/
11期
关键词:
Polycythemia vera;
Cardiomyopathy hypertrophic;
Hypertension;
Thrombosis;
Case report;
MYELOPROLIFERATIVE NEOPLASMS;
WORKING GROUP;
THROMBOSIS;
RISK;
D O I:
10.4330/wjc.v16.i11.651
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
BACKGROUND The combination of polycythemia vera (PV) with pathological cardiac hypertrophy is uncommon. In this study, we describe a case of PV accompanied by pathological cardiac hypertrophy. It is hypothesized that the pronounced cardiac hypertrophy in this patient has a strong connection with PV. CASE SUMMARY In 2021, a 34-year-old Chinese man experienced chest constriction, shortness of breath, and palpitations during vigorous activity. Each episode lasted several minutes and resolved spontaneously following cessation of vigorous activity. He occasionally experienced syncope and vertigo without a headache. He underwent cardiac magnetic resonance imaging and was diagnosed with "hypertrophic cardiomyopathy (HCM)". He was discharged after receiving symptomatic treatment, which resulted in an improvement. He presented to our department with chest constriction, shortness of breath, and respiratory distress for one month while climbing to the second floor in 2023. His blood pressure was 180/100 mmHg at the time of admittance, and he was receiving antihypertensive treatment. He had a history of PV for 2 years without treatment. Symptomatic treatment was implemented concurrently with the administration of hydroxyurea upon admission. Good blood pressure control was observed during the long-term follow-up, and echocardiography did not reveal any progression of myocardial hypertrophy. CONCLUSION Clinicians managing PV patients should remain highly vigilant regarding the risks of thrombosis and cardiovascular complications, particularly in those with refractory hypertension.
引用
收藏
页码:651 / 659
页数:10
相关论文
共 50 条